Principal Investigator
Eugene Schiff
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20241056
Clinical Trial Summary
A randomised, double-blind, placebo-controlled, multicentre,
Phase III trial evaluating long-term efficacy and safety of
survodutide weekly injections in adult participants with noncirrhotic
non-alcoholic steatohepatitis/metabolic associated
steatohepatitis (NASH/MASH) and (F2) - (F3) stage of liver
fibrosis
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu